<DOC>
	<DOCNO>NCT01312714</DOCNO>
	<brief_summary>Vitamin D deficiency highly prevalent among dialysis patient , associate cardiovascular risk factor increase aortic pulse wave velocity , blood pressure , inflammation , brain natriuretic peptide . This study evaluate effect 26 week vitamin D3 supplementation patient end stage renal disease .</brief_summary>
	<brief_title>Vitamin D3 Supplementation Dialysis Patients</brief_title>
	<detailed_description />
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Hemodialysis peritoneal dialysis &gt; 3 month Hypercalceamia Cancer Inability give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Hemodialysis</keyword>
	<keyword>Peritoneal dialysis</keyword>
	<keyword>Vitamin D Deficiency</keyword>
	<keyword>blood pressure</keyword>
	<keyword>arterial stiffness</keyword>
	<keyword>Heart function</keyword>
	<keyword>Renin-angiotensin system</keyword>
	<keyword>Calcium</keyword>
	<keyword>FGF-23</keyword>
	<keyword>Brain natriuretic peptide</keyword>
</DOC>